BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6669393)

  • 1. Silver sulfadiazine (AgSD) resistant pseudomonas infection in experimental burn wounds.
    Modak SM; Stanford JW; Bradshaw W; Fox CL
    Panminerva Med; 1983; 25(3):181-8. PubMed ID: 6669393
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.
    Modak S; Fox CL
    J Trauma; 1985 Jan; 25(1):27-31. PubMed ID: 3917512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between Alpha and silver sulfadiazine ointments in treatment of Pseudomonas infections in 3rd degree burns.
    Hosseini SV; Tanideh N; Kohanteb J; Ghodrati Z; Mehrabani D; Yarmohammadi H
    Int J Surg; 2007 Feb; 5(1):23-6. PubMed ID: 17386910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
    Robb EC; Nathan P
    J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
    Modak SM; Fox CL
    Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of silver lactate and silver sulfadiazine on experimental burn wound sepsis.
    Cossman DV; Krizek TJ
    Surg Forum; 1971; 22():495-7. PubMed ID: 5121452
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology and clinical use of silver sulfadiazine and related topical antimicrobial agents.
    Fox CL
    Pahlavi Med J; 1977 Jan; 8(1):45-64. PubMed ID: 834468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microbiological analysis of experimental burn wounds in swine during treatment with silver sulfadiazine].
    Denys A; Grzybowski A; Białek J; Horoszewicz-Małafiej A; Korczak E; Kowalska M; Małafiej E; Szydłowska T
    Med Dosw Mikrobiol; 1983; 35(2):155-62. PubMed ID: 6423917
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate.
    Saffer LD; Rodeheaver GT; Hiebert JM; Edlich RF
    Surg Gynecol Obstet; 1980 Aug; 151(2):232-6. PubMed ID: 6773164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental burn wound sepsis: variations in response to topical agents.
    Krizek TJ; Cossman DV
    J Trauma; 1972 Jul; 12(7):553-62. PubMed ID: 4625533
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of different topical agents on pseudomonas infection of burn wound].
    Guo Z; Gao W; He L
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1995 Nov; 11(6):421-4. PubMed ID: 8728928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds.
    Modak SM; Sampath L; Fox CL
    J Burn Care Rehabil; 1988; 9(4):359-63. PubMed ID: 3146573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo comparison of two silver sulfadiazine antimicrobial agents on burn wound infection.
    Velanovich V; Heggers JP; Robson MC; Zoellner SM; McHugh TP; Boertman J; Niu XT; Schileru R
    J Burn Care Rehabil; 1987; 8(5):381-3. PubMed ID: 3667664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
    Salisbury RE; Bevin AG; Steinkraus GE; Enterline DS
    J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of controlled topical delivery of silver sulfadiazine in infected burn wounds.
    Shanmugasundaram N; Uma TS; Ramyaa Lakshmi TS; Babu M
    J Biomed Mater Res A; 2009 May; 89(2):472-82. PubMed ID: 18431769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical therapy and the development of silver sulfadiazine.
    Fox CL
    Surg Gynecol Obstet; 1983 Jul; 157(1):82-8. PubMed ID: 6857475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc sulfadiazine for topical therapy of pseudomonas infection in burns.
    Fox CL; Modak SM; Stanford JW
    Surg Gynecol Obstet; 1976 Apr; 142(4):553-9. PubMed ID: 816019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection.
    Fox CL; Rao TN; Azmeth R; Gandhi SS; Modak S
    J Burn Care Rehabil; 1990; 11(2):112-7. PubMed ID: 2335547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
    Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
    J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of in vitro sensitivity to sulfadiazine silver.
    McManus AT; Denton CL; Mason AD
    Arch Surg; 1983 Feb; 118(2):161-6. PubMed ID: 6401421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.